Skip to content

Independent safety-in-use study

SeneDerm Eye Creme AGE Defense — eye-area safety

A two-week ophthalmologist-supervised safety-in-use study evaluated the eye area, including contact-lens wearers.

maintained by Alan Kante · owner, SeneGence International · verified 2026-07-10

Source
Essex Testing Clinic, Panel 21663
Last verified
2026-07-10
Method
Single-blind ophthalmologist-supervised safety-in-use evaluation
Sample
31 enrolled; 30 completed
Significance
No irritation observed; no clinically relevant visual-acuity changes
Evidence record scope master. A reusable evidence header with fields for tested article, record type, method, sample, endpoint, duration, result, and qualification.

scoped claims

claim 01

ophthalmologist-tested and safe for contact-lens wearers

SeneDerm Eye Creme AGE Defense was independently ophthalmologist-tested and found safe for the eye area, including for contact-lens wearers.

Scope
SeneDerm Eye Creme AGE Defense finished product
Endpoint
ophthalmologist-supervised eye-area safety in use
Duration
2 weeks

qualification

what can this evidence support?

This record applies only to the named source, claim scope, endpoint, method, sample, and duration.

  1. →The Clinical Filelearn
  2. →Read the full clinical reportclinical report